Clinical Trial Update: Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of docetaxel and gefitinib (ZD1839) in patients with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gefitinib (Gefitinib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED